Anya Biopharm Inc. (7776.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$32.40 (+1.41%) as of
Key statistics
- Market cap
- 1.59B
- EPS (TTM)
- -1.00
- Dividend yield
- 0.00%
- 52-week range
- 21.50 – 52.00
- Beta
- -0.28
- Revenue (TTM)
- 13.06M
- Profit margin
- 0.00%
- Volume
- 100.91k
About Anya Biopharm Inc.
Anya Biopharm Inc., a pharmaceutical company, research and development of new biotech drugs, focusing on oral peptides and converting injectable drugs into oral formulations in Taiwan, the rest of Asia, and Europe. The company is also developing ANY002 and ANY004, oral GLP1 products; ANY003, a tnfa inhibitor; and ANY005. In addition, it engages in the research, development, and testing business. Anya Biopharm Inc. was founded in 2016 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.